Which has grown faster, MRNA or NTRA?

Over the past five years, NTRA grew revenue faster — MRNA at a 19.33% CAGR versus NTRA at 39.92%.

How have MRNA and NTRA total returns compared?

Over the past 5 years, MRNA delivered -11.04% and NTRA delivered 29.55% annualized total return. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Natera, Inc. (NTRA)

A side-by-side comparison of Moderna, Inc. and Natera, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.

MRNA

Moderna, Inc.

$75.39B

$190.01HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

NTRA

Natera, Inc.

$58.77B

$410.35HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — MRNA vs NTRA

growth of $100 · dividends reinvested · last 8y

MRNA +921.6% (+33.7%/yr)NTRA +2251.6% (+48.4%/yr)NTRA compounded faster over this window

MRNA NTRA

MRNA vs NTRA: by the numbers

•MRNA is the larger company ($75.39B vs $58.77B market cap).
•Both run net losses; NTRA's is the smaller (-7.11% vs -141.43% net margin).
•NTRA grew revenue faster over the past five years (39.92% vs 19.33% CAGR).

Metrics side by side

Valuation

Metric	MRNA	NTRA
P/S ratio	33.84	21.71
P/B ratio	11.15	32.26
FCF yield	N/A	0.12%

Profitability

Metric	MRNA	NTRA
Gross margin	55.35%	65.30%
Operating margin	-158.13%	-10.70%
Net margin	-141.43%	-7.11%
ROE	-46.61%	-10.56%
ROIC	-39.16%	-13.26%

Growth (annualized)

Metric	MRNA	NTRA
Revenue CAGR (5Y)	19.33%	39.92%
Total return CAGR (5Y)	-11.04%	29.55%

Frequently asked

Which has grown faster, MRNA or NTRA?: Over the past five years, NTRA grew revenue faster — MRNA at a 19.33% CAGR versus NTRA at 39.92%.
How have MRNA and NTRA total returns compared?: Over the past 5 years, MRNA delivered -11.04% and NTRA delivered 29.55% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full NTRA analysis Interactive comparison tool

Dig into the metrics

Moderna ROE Natera ROE Moderna operating margin Natera operating margin Moderna revenue growth Natera revenue growth Moderna free cash flow Natera free cash flow

Moderna & Natera appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.